Multidrug-resistant tuberculosis
MONDO:0005861A type of drug-resistant tuberculosis that is resistant to both rifampicin and isoniazid, the two most powerful anti-TB drugs.
Also known as: MDR-TB, multidrug-resistant TB
42 clinical trials for this condition and its sub-types, 36 tagged with Multidrug-resistant tuberculosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Could aspirin or ibuprofen help beat TB faster?
Disease control Stopped earlyThis study tested whether adding aspirin or ibuprofen to standard tuberculosis (TB) treatment helps patients recover more quickly. It included 426 adults with drug-sensitive or drug-resistant TB. The trial was terminated early, so the results are not conclusive.
Phase 2 • Sponsor: Fundació Institut Germans Trias i Pujol • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New TB drug cocktails aim to cut treatment time in half
Disease control Stopped earlyThis clinical trial tested whether combining several drugs—bedaquiline, OPC-167832, sutezolid, and either pretomanid or delamanid—could treat pulmonary tuberculosis in just 2 to 4 months instead of the standard 6 months. The study enrolled 93 adults with drug-sensitive or drug-re…
Phase 2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC